Cite
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
MLA
Schrader, Anne M. R., et al. “High Prevalence of MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma.” Blood, vol. 131, no. 18, May 2018, pp. 2086–89. EBSCOhost, https://doi.org/10.1182/blood-2017-12-822817.
APA
Schrader, A. M. R., Jansen, P. M., Willemze, R., Vermeer, M. H., Cleton-Jansen, A.-M., Somers, S. F., Veelken, J. H. (Hendrik), van Eijk, R., Kraan, W., Kersten, M. J., den Brand, M. van, Stevens, W. B. C., de Jong, D., Hamid, M. A., Tanis, B. C., Posthuma, E. F. M., Nijland, M., Diepstra, A., Pals, S. T., & Cleven, A. H. G. (2018). High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood, 131(18), 2086–2089. https://doi.org/10.1182/blood-2017-12-822817
Chicago
Schrader, Anne M. R., Patty M. Jansen, Rein Willemze, Maarten H. Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F. Somers, J. H. (Hendrik) Veelken, et al. 2018. “High Prevalence of MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma.” Blood 131 (18): 2086–89. doi:10.1182/blood-2017-12-822817.